Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruiting
NCT04398628N/AUpdated Jul 13, 2026
Sponsor: American Thrombosis and Hemostasis Network
Hematologic Disorder · Bleeding Disorder · Connective Tissue Disorder · Hemophilia
United States
Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects and HFpEF PatientsActive Not Recruiting
NCT04998877N/AUpdated Jul 13, 2026
Sponsor: Johns Hopkins University
Heart Failure With Preserved Ejection Fraction
United States
COcoa Supplement and Multivitamin Outcomes StudyCompleted
NCT02422745Phase 4Updated Jul 13, 2026
Sponsor: Brigham and Women's Hospital
Cardiovascular Disease · Cancer
United States
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone AcetateRecruiting
NCT06844383Phase 2Updated Jul 13, 2026
Sponsor: Prostate Cancer Clinical Trials Consortium
Prostate Cancer (Adenocarcinoma) · mCRPC (Metastatic Castration-resistant Prostate Cancer)
United States
Safety And Efficacy Of BosutinibCompleted
NCT02501330N/AUpdated Jul 10, 2026
Sponsor: Pfizer
Chronic Myelogenous Leukemia
A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese MarketCompleted
NCT07096024N/AUpdated Jul 10, 2026
Sponsor: Pfizer
Breast Neoplasms
United States
A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other OrgansCompleted
NCT06003114N/AUpdated Jul 10, 2026
Sponsor: Pfizer
Breast Cancer
Canada
Secondary Databased Post-marketing Surveillance Study of BNT162b2Completed
NCT06743334N/AUpdated Jul 10, 2026
Sponsor: Pfizer
COVID-19 · SARS-CoV-2
South Korea
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.Completed
NCT06678555N/AUpdated Jul 10, 2026
Sponsor: Pfizer
Carcinoma, Non-Small-Cell Lung
Taiwan
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.Recruiting
NCT05355701Phase 1Updated Jul 9, 2026
Sponsor: Pfizer
Melanoma · Non-Small-Cell Lung Cancer · Thyroid Cancer · Glioma
United States, Canada, Israel
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual MigraineRecruiting
NCT06641466Phase 3Updated Jul 9, 2026
Sponsor: Pfizer
Menstrual Migraine
United States, Argentina, Canada, China, Denmark +10 more
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.Recruiting
NCT07028853Phase 3Updated Jul 9, 2026
Sponsor: Pfizer
Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Hormone Sensitive Prostate Cancer · Prostate Cancer · Cancer of the Prostate
United States, Argentina, Australia, Belgium, Brazil +21 more
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsRecruiting
NCT05538130Phase 1Updated Jul 9, 2026
Sponsor: Pfizer
Melanoma · Glioma · Thyroid Cancer · Non-Small Cell Lung Cancer
United States, Australia, Brazil, Canada, China +2 more
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely ImmunocompromisedRecruiting
NCT07013474Phase 3Updated Jul 9, 2026
Sponsor: Pfizer
COVID-19 Infection
United States, Argentina, Belgium, Brazil, Denmark +13 more
A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or ObesityActive Not Recruiting
NCT07508241Phase 1Updated Jul 9, 2026
Sponsor: Pfizer
Obesity · Overweight and/or Obesity · Overweight · Drug Interaction
United States
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and AdolescentsRecruiting
NCT07660198Phase 3Updated Jul 9, 2026
Sponsor: Pfizer
Pneumococcal Disease
United States, Puerto Rico
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their BabiesRecruiting
NCT07160244Phase 3Updated Jul 9, 2026
Sponsor: Pfizer
Healthy
United States, Argentina, Brazil, Canada, Finland +8 more
A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreFNot Yet Recruiting
NCT07653100Phase 3Updated Jul 9, 2026
Sponsor: Pfizer
Respiratory Syncytial Virus (RSV)
India
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for TransplantRecruiting
NCT05623020Phase 3Updated Jul 9, 2026
Sponsor: Pfizer
Multiple Myeloma
United States, Australia, Austria, Belgium, Brazil +19 more
Randomized Study in Children and Adolescents With Migraine: Acute TreatmentRecruiting
NCT04649242Phase 3Updated Jul 9, 2026
Sponsor: Pfizer
Pediatric Migraine
United States, Canada, China, Japan, Mexico +4 more
A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related DiseasesCompleted
NCT05742217N/AUpdated Jul 9, 2026
Sponsor: Pfizer
Relapse Multiple Myeloma · Refractory Multiple Myeloma
Italy
Relative Bioavailability and Impact of Rabeprazole for PF-07799933, Food-Effect for PF-07799933 and PF-07799544Completed
NCT07563894Phase 1Updated Jul 9, 2026
Sponsor: Pfizer
Healthy
United States
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.Recruiting
NCT06629779Phase 3Updated Jul 9, 2026
Sponsor: Pfizer
Metastatic Castration-Resistant Prostate Cancer
United States, Argentina, Brazil, Bulgaria, Canada +22 more
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.Recruiting
NCT07228390Phase 2Updated Jul 9, 2026
Sponsor: Pfizer
Hidradenitis Suppurativa
United States, Canada, Germany, Greece, Poland +1 more
A Study to Understand What the Body Does to the Study Medicine Called PF-07799544 When Taken by Healthy AdultsRecruiting
NCT07578636Phase 1Updated Jul 9, 2026
Sponsor: Pfizer
Healthy Male Volunteers
United States

Previous page Next page